Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Authors: Bajema KL, Wiegand RE, Cuffe K, Patel SV, Iachan R, Lim T, Lee A, Moyse D, Havers FP, Harding L, Fry AM, Hall AJ, Martin K, Biel M, Deng Y, Meyer WA 3rd, Mathur M, Kyle T, Gundlapalli AV, Thornburg NJ, Petersen LR, Edens C.

Citation: JAMA Intern Med. 2020 Nov 24;e207976. doi: 10.1001/jamainternmed.2020.7976. Online ahead of print.

Specialties: COVID-19, Infectious Disease

Download key summary

Related content

Publication
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022
Publication
Seroprevalence of SARS CoV 2 Specific IgG Antibodies Among Adults Living in Connecticut Post Infection Prevalence PIP Study
Publication
SARS-CoV-2 positivity rates associated with circulating 25 hydroxyvitamin D levels
Publication
Insights from Patterns of SARS CoV 2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory United States March July 2020
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.